| 产品描述: | iCRT-14是β-catenin应答转录(CRT)抑制剂,在wnt通路实验中IC50为40.3 nM;iCRT-14 is a novel potent inhibitor of β-catenin-responsive transcription (CRT) (IC50 = 40.3 nM in assays of Wnt pathway activity).A potent beta-catenin inhibitor |
| 靶点: |
IC50: 40.3 nM (Wnt responsive STF16 luciferase) |
| 体内研究: |
iCRT 14 (50 mg/kg,腹腔注射) 显著降低 CycD1,即 HCT116 异种移植物中肿瘤的增殖。 |
| 参考文献: |
1. Gonsalves FC, et al. An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc Natl Acad Sci USA. 2011 Apr 12;108(15):5954-63. 2. Bilir B, et al. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J Transl Med. 2013 Nov 4;11:280. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.664 ml |
13.318 ml |
26.635 ml |
| 5 mM |
0.533 ml |
2.664 ml |
5.327 ml |
| 10 mM |
0.266 ml |
1.332 ml |
2.664 ml |
| 50 mM |
0.053 ml |
0.266 ml |
0.533 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |